Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Respiratory Research|February 14, 2023
Mechanisms of pulmonary disease in F344 rats after workplace-relevant inhalation exposure to cross-linked water-soluble acrylic acid polymersShotaro Yamano, Tomoki Takeda, Yuko Goto, et al.
Oncology Research|August 2, 2008
Long-term results of dose-intensive chemotherapy with G-CSF support (TCC-NHL-91) for advanced intermediate-grade non-Hodgkin's lymphoma: a review of 59 consecutive cases treated at a single instituteMiyuki Akutsu, Saburo Tsunoda, Tohru Izumi, et al.
Blood Neoplasia|September 15, 2025
Discovery of a novel class NSD2 inhibitor for multiple myeloma with t(4;14)<sup></sup>Sae Matsuoka, Naoki Osada, Hirokazu Kubota, et al.
Molecular Cancer Therapeutics|December 6, 2015
Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome-Positive Lymphoid LeukemiaAtsushi Nemoto, Satoshi Saida, Itaru Kato, et al.
Particle and Fibre Toxicology|April 9, 2022
Dose-response relationship of pulmonary disorders by inhalation exposure to cross-linked water-soluble acrylic acid polymers in F344 ratsTomoki Takeda, Shotaro Yamano, Yuko Goto, et al.
Cell Metabolism|September 3, 2009
Ablation of neutral cholesterol ester hydrolase 1 accelerates atherosclerosisMotohiro Sekiya, Jun-Ichi Osuga, Shuichi Nagashima, et al.
Blood|June 4, 2010
Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19)Kinuko Hirose, Takeshi Inukai, Jiro Kikuchi, et al.
Plos One|December 14, 2017
Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell linesKazuya Takahashi, Takeshi Inukai, Toshihiko Imamura, et al.
Pageof 12